|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 22026 |
FusionGeneSummary for MIR548G_F2R |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MIR548G_F2R | Fusion gene ID: 22026 | Hgene | Tgene | Gene symbol | MIR548G | F2R | Gene ID | 100313938 | 2149 |
| Gene name | microRNA 548g | coagulation factor II thrombin receptor | |
| Synonyms | MIRN548G|hsa-mir-548g | CF2R|HTR|PAR-1|PAR1|TR | |
| Cytomap | 4q31.22 | 5q13.3 | |
| Type of gene | ncRNA | protein-coding | |
| Description | - | proteinase-activated receptor 1protease-activated receptor 1 | |
| Modification date | 20180329 | 20180523 | |
| UniProtAcc | P25116 | ||
| Ensembl transtripts involved in fusion gene | ENST00000408442, | ENST00000319211, ENST00000505600, | |
| Fusion gene scores | * DoF score | 3 X 4 X 1=12 | 4 X 4 X 2=32 |
| # samples | 4 | 4 | |
| ** MAII score | log2(4/12*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: MIR548G [Title/Abstract] AND F2R [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | F2R | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 9639571 |
| Tgene | F2R | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 10692450 |
| Tgene | F2R | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | 20164183 |
| Tgene | F2R | GO:0008285 | negative regulation of cell proliferation | 10692450 |
| Tgene | F2R | GO:0009611 | response to wounding | 9639571 |
| Tgene | F2R | GO:0030168 | platelet activation | 9038223 |
| Tgene | F2R | GO:0030193 | regulation of blood coagulation | 17848177 |
| Tgene | F2R | GO:0030194 | positive regulation of blood coagulation | 9038223 |
| Tgene | F2R | GO:0032967 | positive regulation of collagen biosynthetic process | 9639571 |
| Tgene | F2R | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 10692450 |
| Tgene | F2R | GO:0043410 | positive regulation of MAPK cascade | 17848177 |
| Tgene | F2R | GO:0045893 | positive regulation of transcription, DNA-templated | 17848177 |
| Tgene | F2R | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1672265 |
| Tgene | F2R | GO:2000484 | positive regulation of interleukin-8 secretion | 17404307 |
| Tgene | F2R | GO:2000778 | positive regulation of interleukin-6 secretion | 11447194 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BU677108 | MIR548G | chr3 | 99516394 | - | F2R | chr5 | 76031016 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000408442 | ENST00000319211 | MIR548G | chr3 | 99516394 | - | F2R | chr5 | 76031016 | - |
| intron-intron | ENST00000408442 | ENST00000505600 | MIR548G | chr3 | 99516394 | - | F2R | chr5 | 76031016 | - |
Top |
FusionProtFeatures for MIR548G_F2R |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MIR548G | F2R |
| Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. | High affinity receptor for activated thrombin coupled toG proteins that stimulate phosphoinositide hydrolysis. May play arole in platelets activation and in vascular development.{ECO:0000269|PubMed:10079109}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MIR548G_F2R |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MIR548G_F2R |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MIR548G_F2R |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | F2R | P25116 | DB09030 | Vorapaxar | Proteinase-activated receptor 1 | small molecule | approved |
| Tgene | F2R | P25116 | DB00086 | Streptokinase | Proteinase-activated receptor 1 | biotech | approved|investigational |
| Tgene | F2R | P25116 | DB11300 | Thrombin | Proteinase-activated receptor 1 | small molecule | approved|investigational |
Top |
RelatedDiseases for MIR548G_F2R |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | F2R | C0015695 | Fatty Liver | 3 | CTD_human |
| Tgene | F2R | C0019158 | Hepatitis | 1 | CTD_human |
| Tgene | F2R | C0021368 | Inflammation | 1 | CTD_human |
| Tgene | F2R | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| Tgene | F2R | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | F2R | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
| Tgene | F2R | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|